Our patient is a 26-week-old preterm female infant delivered by caesarean section secondary to severe maternal preeclampsia who had been receiving subcutaneous recombinant erythropoietin (r-EPO) for anemia of prematurity. At 8 weeks of age after 8 doses of r-EPO, the infant developed numerous non-blanching erythematous macules and patches located on the back, posterior shoulder, and posterior arms, concerning for late-onset blueberry muffin lesions. Biopsy of the lesions confirmed dermal hematopoiesis. After r-EPO was discontinued all skin lesions gradually resolved over a period of 2 weeks and never recurred. © 2013 by the article author(s).
CITATION STYLE
Rajpara, A., Blackmon, J., Laarman, R., Skaggs, R., Liolios, A., Liu, D., & Fraga, G. (2013). Preterm infant with a late presentation of blueberry muffin lesions secondary to recombinant erythropoietin. Dermatology Online Journal, 19(9). https://doi.org/10.5070/d3199019618
Mendeley helps you to discover research relevant for your work.